US-based biotechnology firm GeoVax Labs has received a notice of allowance from the US Patent and Trademark Office (USPTO) for patent that covers compositions, methods and uses of the company's DNA/MVA vaccine in eliciting cellular and ...
Tags: Geovax Labs, HIV/Aids Vaccine